World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
111
Citations
40805
World Ranking
5371
National Ranking
2897

Neuroscience

D-Index
110
Citations
40586
World Ranking
544
National Ranking
310

Gavril W. Pasternak publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Gavril W. Pasternak sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 452 publications — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Gavril W. Pasternak D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Gavril W. Pasternak sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 110 D-Index — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Gavril W. Pasternak was affiliated with the Memorial Sloan Kettering Cancer Center in the United States. Their research primarily focused on fields within Biochemistry, Genetics and Molecular Biology, as well as Neuroscience, contributing 12 and 8 publications respectively. Subfields of study that featured prominently in their work included Molecular Biology, Cellular and Molecular Neuroscience, Pharmacology, Biochemistry, and Organic Chemistry.

The scientist's work addressed several main topics including Neuropeptides and Animal Physiology, Receptor Mechanisms and Signaling, Pharmacological Receptor Mechanisms and Effects, Alkaloids: synthesis and pharmacology, Traditional and Medicinal Uses of Annonaceae, Chemical synthesis and alkaloids, and Nerve injury and regeneration.

Frequent publication venues for Pasternak included:

  • Cellular and Molecular Neurobiology
  • ACS Chemical Neuroscience
  • eLife
  • Journal of Medicinal Chemistry
  • Cell stem cell

Their recent notable publications comprised:

  • "Controlling opioid receptor functional selectivity by targeting distinct subpockets of the orthosteric site," 2021, eLife
  • "Oxidative Metabolism as a Modulator of Kratom's Biological Actions," 2021, Journal of Medicinal Chemistry
  • "Deriving Schwann cells from hPSCs enables disease modeling and drug discovery for diabetic peripheral neuropathy," 2023, Cell stem cell
  • "Kratom Alkaloids as Probes for Opioid Receptor Function: Pharmacological Characterization of Minor Indole and Oxindole Alkaloids from Kratom," 2021, ACS Chemical Neuroscience
  • "Mu Opioids Induce Biased Signaling at the Full-Length Seven Transmembrane C-Terminal Splice Variants of the mu Opioid Receptor Gene, Oprm1," 2020, Cellular and Molecular Neurobiology

The scientist collaborated frequently with several coauthors, including Amanda Hunkele, Ying-Xian Pan, Rajendra Uprety, Susruta Majumdar, and András Váradi.

Best Publications

  • Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain

    Roger Chou;Gilbert J. Fanciullo;Perry G. Fine;Jeremy A. Adler

  • Strategies to Manage the Adverse Effects of Oral Morphine: An Evidence-Based Report

    Nathan Cherny;Carla Ripamonti;Jose Pereira;Carol Davis

  • Pharmacological mechanisms of opioid analgesics.

    Gavril W. Pasternak

  • Opiate Agonists and Antagonists Discriminated by Receptor Binding in Brain

    Candace B. Pert;Gavril Pasternak;Solomon H. Snyder

  • Mu Opioids and Their Receptors: Evolution of a Concept

    Gavril W. Pasternak;Ying Xian Pan

  • The Molecular and Behavioral Pharmacology of the Orphanin FQ/Nociceptin Peptide and Receptor Family

    Jeffrey S. Mogil;Gavril W. Pasternak

  • Retention of Supraspinal Delta-like Analgesia and Loss of Morphine Tolerance in δ Opioid Receptor Knockout Mice

    Yanxin Zhu;Michael A. King;Alwin G.P. Schuller;Joshua F. Nitsche

  • Classification of multiple morphine and enkephalin binding sites in the central nervous system

    Benjamen L. Wolozin;Gavril W. Pasternak

  • Minireview: Multiple MU opiate receptors

    Gavril W. Pasternak;Paul J. Wood

  • An endogenous morphine-like factor in mammalian brain.

    Gavril W. Pasternak;Robert Goodman;Solomon H. Snyder

  • Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite.

    D Paul;K M Standifer;C E Inturrisi;G W Pasternak

  • Morphine-6-glucuronide, a potent mu agonist

    Gavril W. Pasternak;Richard J. Bodnar;Richard J. Bodnar;Janet A. Clark;Charles E. Inturrisi;Charles E. Inturrisi

  • Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1.

    Alwin G.P. Schuller;Michael A. King;Jiwen Zhang;Elizabeth Bolan

  • Kappa opiate receptor multiplicity: evidence for two U50,488-sensitive kappa 1 subtypes and a novel kappa 3 subtype.

    J A Clark;L Liu;M Price;B Hersh

  • The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids.

    Kathryn Elliott;Nobuko Minami;Yuri A. Kolesnikov;Gavril W. Pasternak;Gavril W. Pasternak

  • Separation of Opioid Analgesia from Respiratory Depression: Evidence for Different Receptor Mechanisms

    G. S. F. Ling;K. Spiegel;S. H. Lockhart;G. W. Pasternak

  • Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor

    Tao Che;Susruta Majumdar;Saheem A. Zaidi;Pauline Ondachi

  • Differential effects of protein-modifying reagents on receptor binding of opiate agonists and antagonists.

    Pasternak Gw;Wilson Ha;Snyder Sh

  • Opiate Analgesia: Evidence for Mediation by a Subpopulation of Opiate Receptors

    Gavril W. Pasternak;Stephen R. Childers;Solomon H. Snyder

  • Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor.

    Yuri A. Kolesnikov;Chaim G. Pick;Grazyna Ciszewska;Gavril W. Pasternak

Frequent Co-Authors

Grace C. Rossi
Grace C. Rossi Long Island University
Richard J. Bodnar
Richard J. Bodnar Queens College, CUNY
Solomon H. Snyder
Solomon H. Snyder Johns Hopkins University School of Medicine
John E. Pintar
John E. Pintar Rutgers, The State University of New Jersey
Chaim G. Pick
Chaim G. Pick Tel Aviv University
Bryan L. Roth
Bryan L. Roth University of North Carolina at Chapel Hill
Jonathan A. Javitch
Jonathan A. Javitch Columbia University
Urs Rutishauser
Urs Rutishauser Memorial Sloan Kettering Cancer Center
Xi Ping Huang
Xi Ping Huang University of North Carolina at Chapel Hill
Ellen M. Unterwald
Ellen M. Unterwald Temple University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are interested in Neuroscience, many related online degrees can expand your career options in allied fields. For example, pursuing a Master of Social Work (MSW) can prepare graduates for work in mental health and healthcare settings, particularly when considering the cheapest msw programs online or looking for msw programs with flexible schedules.

Those interested in behavioral analysis may find that bcba certification programs online offer a cost-effective route to professional certification. Board Certified Behavior Analysts work not just in neuroscience, but also in education and clinical environments.

Additionally, for students looking to accelerate their path toward a career in psychology, there are many accelerated psychology programs online. These can open doors to roles such as counselor, mental health advocate, or research assistant. Overall, a background in neuroscience pairs well with these fast-growing, flexible degree options for a dynamic career path in health and science.

Best Scientists Citing Gavril W. Pasternak

Recently Published Articles